M1 macrophages, associated with a pro-inflammatory and anti-tumor phenotype, typically exhibit higher levels of NLRP3 activity, while M2 macrophages are characterized by reduced NLRP3 activity, consistent with their anti-inflammatory profile and tumor-promoting effects [19]. The gene discussed is NLRP3; the disease is neoplasm.